Диссертация (1139785), страница 26
Текст из файла (страница 26)
Ponikowski P, van Veldhuisen DJ, Comin-Colet J et al. / Beneficial effects oflong-term intravenous iron therapy with ferric carboxymaltose in patients withsymptomatic heart failure and iron deficiency // European Heart Journal.2015;36(11):657–68.179. Poole-Wilson PA, Swedberg K, Cleland JG et al. / Comparison of carvedilol andmetoprolol on clinical outcomes in patients with chronic heart failure in the CarvedilolOr Metoprolol European Trial (COMET): randomised controlled trial // Lancet.2003;362 (9377):7–13.139180. Prevention of cardiovascular events and death with pravastatin in patients withcoronary heart disease and a broad range of initial cholesterol levels. The Long-TermIntervention with Pravastatin in Ischaemic Disease (LIPID) Study Group // N Engl JMed.
1998.339 (19):1349–1357.181. Randomised, placebo-controlled trial of carvedilol in patients with congestive heartfailure due to ischaemic heart disease. Australia/New Zealand Heart Failure ResearchCollaborative Group // Lancet. 1997;349 (9049):375–380182. Rathore SS, Curtis JP, Wang Y et al. / Association of serum digoxin concentrationand outcomes in patients with heart failure // JAMA. 2003;289 (7):871–878.183.
Reiner Z, Catapano AL, De Backer G et al. / ESC/EAS Guidelines for themanagement of dyslipidaemias: the Task Force for the management of dyslipidaemiasof the European Society of Cardiology (ESC) and the European Atherosclerosis Society(EAS) // Eur Heart J 2011;32:1769–1818.184. Sica DA, Cutler RE, Parmer RJ et al.
/ Comparison of the steady-statepharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renalinsufficiency // Clin Pharmacokinet. 1991;20(5):420–427.185. Silvestre J., Heymes C., Abdesalam O. et al. / Activation of cardiac aldosteroneproduction in rat myocardial infarction: effect of angiotensin II receptor blockade androle in cardiac fibrosis // Circulation 1999; 99 (20): 2694–701186.
Shekelle P.G., Rich M.W., Morton S.C. / Efficacy of angiotensin-convertingenzyme inhibitors and beta-blockers in the management of left ventricular systolicdysfunction according to race, gender, and diabetic status. A meta-analysis of majorclinical trials // J Am Coll Cardiol. 2003;41 (9):1529–1538187. Sherlock S, Dick R, Van Leeuwen DJ. / Liver biopsy today. The Royal FreeHospital experience // J Hepatol. 1985;1(1):75-85.188. SOLVD Investigattors.
Effect of enalapril on survival in patients with reduced leftventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293–302.140189. Spaulding C, Charbonnier B, Cohen-Solal A et al. / Acute hemodynamicinteraction of aspirin and ticlopidine with enalapril: results of a double-blind,randomized comparative trial // Circulation. 1998.
98 (8):757–765.190. Stewart S, Jenkins A, Buchan S et al. / The current cost of heart failure to theNational Health Service in the UK // Eur J Heart Fail 2002;4:361–371.191. Svensson M, Gustafsson F, Galatius S et al. / How prevalent is hyperkalemia andrenal dysfunction during treatment with spironolactone in patients with congestive heartfailure? // J Card Fail. 2004;10 (4):297–303.192. Swedberg K, Komajda M, Böhm M et al. / Ivabradine and outcomes in chronicheart failure (SHIFT): a randomised placebo-controlled study // Lancet 2010;376:875–885.193. Swedberg K, Zannad F, McMurray JJ et al.
/ Eplerenone and atrial fibrillation inmild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in MildPatients Hospitalization And SurvIval Study in Heart Failure) study // J Am CollCardiol. 2012;59 (18):1598–1603.194. Tavazzi L, Maggioni AP, Marchioli R et al. / Effect of n-3 polyunsaturated fattyacids in patients with chronic heart failure (the GISSI-HF trial): a randomised, doubleblind, placebo-controlled trial // Lancet 2008. 372:1223–1230.195.
Taylor PJ, Cooper DP, Gordon RD, Stowasser M. / Measurement of Aldosteronein Human Plasma by Semiautomated HPLC–Tandem Mass Spectrometry // ClinicalChemistry June 2009; 55(6): 1155–62196. Taylor PJ, Rosendal SP, Coombes JS et al. / Simultaneous measurement ofaldosterone and cortisol by high-performance liquid chromatography–tandem massspectrometry:Applicationtodehydration–rehydrationstudies//JournalofChromatography B 2010; 878: 1195–8.197.
Teo KK, Yusuf S, Pfeffer M et al. / Effects of long-term treatment withangiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: asystematic review // Lancet. 2002;360 (9339):1037–1043.198. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial.Lancet. 1999;353 (9146):9–13.141199. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severecongestive heart failure. Results of the Cooperative North Scandinavian EnalaprilSurvival Study (CONSENSUS). N Engl J Med 1987;316:1429–1435.200. The NETWORK Investigators.
Clinical outcome with enalapril in symptomaticchronic heart failure: a dose comparison. Eur Heart J. 1998;19 (3):481–489.201. The SOLVD Investigators. Effect of enalapril on mortality and the development ofheart failure in asymptomatic patients with reduced left ventricular ejection fractions.
NEngl J Med 1992;327:685–691.202. Tokola O., Pelkonen O., Karki N.T., Luoma P. / Hepatic drug-oxidizing enzymesystems and urinary D-glucaric acid excretion in patients with congestive heart failure //Br J Clin Pharmacol. 1975 Oct; 2(5):429-36.203. Tsuyuki R, Yusuf S, Rouleau J et al. / Combination neurohormonal blockade withACE inhibitors angiotensin II antagonists and beta-blockers in patients with congestiveheart failure: design of the Randomized Evaluation of Strategies for Left VentricularDysfunction (RESOLVD) Pilot Study // Can J Cardiol.
1997;13 (12):1166–1174.204. Turpeinen U, Hämäläinen E, Sterman UH. Determination of aldesterone in serumby liquid chromatography-tandem mass spectrometry. J of Chromatog B 2008; 862(1–2): 113–8.205. Udelson JE, Feldman AM, Greenberg B et al. / Randomized, doubleblind,multicenter, placebo-controlled study evaluating the effect of aldosterone antagonismwith eplerenone on ventricular remodeling in patients with mild-to-moderate heartfailure and left ventricular systolic dysfunction // Circ Heart Fail. 2010;3 (3):347–353.206.
Vamos M, Erath JW, Hohnloser SH / Digoxin-associated mortality: a systematicreview and meta-analysis of the literature // Eur Heart J 2015;36:1831–1838.207. Van den Noort N. / The development of an automated online XLC-MS/MS methodfor the determination of aldosterone in blood plasma // Amsterdam: UMCG; 2013.208. Van Der Gugten JG, Crawford M, Grant RP, Holmes DT / Supported liquidextraction offers improved sample preparation for aldosterone analysis by liquidchromatography tandem mass spectrometry // J Clin Phthol 2012; 65: 1045–8.142209. Van Gelder IC, Groenveld HF, Crijns HJGM et al. / RACE II Investigators.Lenient versus strict rate control in patients with atrial fibrillation // N Engl J Med2010.362:1363–1373.210. Vantrimpont P, Rouleau JL, Wun CC et al.
/ Additive beneficial effects of betablockers to angiotensin-converting enzyme inhibitors in the Survival and VentricularEnlargement (SAVE) Study. SAVE Investigators // J Am Coll Cardiol. 1997.29(2):229–236.211. Vepsalainen S, Helisalmi S, Mannermaa A, et al.
/ Combined risk effects of IDEand NEP gene variants on Alzheimer disease // J Neurol Neurosurg Psychiatry2009.80:1268–1270.212. Vodovar N, Paquet C, Mebazaa A et al. / Neprilysin, cardiovascular, andAlzheimer's diseases: the therapeutic split? // Eur Heart J 2015.36:902–905.213. Waagstein F, Bristow MR, Swedberg K, et al. / Beneficial effects of metoprolol inidiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) TrialStudy Group // Lancet. 1993;342 (8885):1441–1446.214. Wang J-Q, Wu G-R, Wang Z et al. / Long-term Clinical Outcomes of Statin Usefor Chronic Heart Failure: A Meta-analysis of 15 Prospective Studies // Heart, Lung andCirculation.
2014. 23(2):105–13. DOI:10.1016/j.hlc.2013.07.012215. Wang TJ. / Natural history of asymptomatic left ventricular systolic dysfunction inthe community // Circulation 2003.108:977–982.216. Washam JB, Stevens SR, Lokhnygina Y, et al. / Digoxin use in patients with atrialfibrillation and adverse cardiovascular outcomes: a retrospective analysis of theRivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin KAntagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation(ROCKET AF) // Lancet 2015;385:2363–2370.217. Wildt, de SN, Kearns GL et al. / Cytochrome P450f^h ЗА: ontogeny and drugdisposition// Clin Pharmacokinet 1999. 37(6): 485505.218. Willenheimer R, van Veldhuisen DJ, Silke B et al.
/ Effect on survival andhospitalization of initiating treatment for chronic heart failure with bisoprolol followed143by enalapril, as compared with the opposite sequence: results of the randomized CardiacInsufficiency Bisoprolol Study (CIBIS) III // Circulation. 2005;112 (16):2426–2435.219.
Williams J.S., Williams G.H. / 50th anniversary of aldosterone // J Clin EndocrinolMetab 2003. 88: 2364–72.220. Yamamoto K, Burnett JC, Bermudez EA et al. / Clinical criteria and biochemicalmarkers for the detection of systolic dysfunction // Journal of Cardiac Failure.2000.6(3):194–200. DOI:10.1054/jcaf.2000.9676221. Yamashita K, Okuyama M, Nakagawa R, et al. / Development of sensitivederivatization method for aldosterone in liquid chromatography-electrospray ionizationtandem mass spectrometry of corticosteroids// J of Chromatogr A 2008.1200(2):114-21.222. Yasojima K, McGeer EG, McGeer PL / Relationship between beta amyloid peptidegenerating molecules and neprilysin in Alzheimer disease and normal brain // Brain Res2001. 919:115–121.223. Yusuf S, Pfeffer MA, Swedberg K et al. / Effects of candesartan in patients withchronic heart failure and preserved left-ventricular ejection fraction: the CHARMPreserved Trial // Lancet.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
